Dapoxetine Delay: J&J’s Premature Ejaculation Drug “Not Approvable” At FDA

Alza says it will continue the global development program and address FDA’s questions.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet